GSK seeks European marketing nod for OTC weight loss product
Thursday, October 04, 2007 09:00 IST London, UK
GlaxoSmithKline (GSK) announced its marketing application for non-prescription Orlistat 60mg for weight loss has been accepted for review by the European Agency for the Evaluation of Medicinal Products (EMEA).